Recurrent or Metastatic Breast Cancer
5 clinical trials · Condition
◉ Watch Recurrent or Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR (NCT03947736) | Chinese Academy of Medical Sciences | 2018-09-17 |
| Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer (NCT03326102) | Daehwa Pharmaceutical Co., Ltd. | 2018-07-06 |
| Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy (NCT03315364) | Daehwa Pharmaceutical Co., Ltd. | 2017-12-18 |
| Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer (NCT03109249) | Sun Pharma Advanced Research Company Limited | 2017-01-14 |
Track Recurrent or Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.